Agios Pharmaceuticals raised $220,000,000 on .

Get alertedif Agios Pharmaceuticals gets funded!
Amount:$220,000,000
Company:
Investors:-
Industry:Biotechnology
Country:
State:
City:
United States
Massachusetts
Cambridge
Key people:Craig B. Thompson (Founder)
Lewis C. Cantley (Board of Directors, Co-Founder)
Doug Cole (Board of Directors, Director)
Glenn Goddard (SVP Finance)
Bob Nelsen (Board of Directors)
David Schenkein (CEO, Director, Executive_Officer)
Robert T. Nelsen (Board Member)
Marc Tessier-lavigne (Board of Directors, Director)
Tak W. Mak (Founders)
Min Wang (VP Legal Affairs)
Data sources:
globenewswire.com - Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock: http://t.co/FTkZuciYAx #invest
www.biocentury.com - Agios raises $220M in upsized follow-on http://t.co/qmtc7QxmGs Agios Pharmaceuticals Inc. (NASDAQ:AGIO) raised $220 million through the...
Description:
Agios Pharmaceuticals, a Cambridge, United States-based provider of Biotechnology solutions, closed a 220M financing in December 11th, 2014.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!